肾络通治疗系膜增生性肾小球肾炎的临床观察 |
| |
引用本文: | 赵玉庸,陈志强,于春泉,李春香,董尚朴,王月华.肾络通治疗系膜增生性肾小球肾炎的临床观察[J].中国中西医结合杂志,2002,22(12):909-911. |
| |
作者姓名: | 赵玉庸 陈志强 于春泉 李春香 董尚朴 王月华 |
| |
作者单位: | 河北医科大学中西医结合学院,石家庄050091 |
| |
摘 要: | 目的:探讨肾络通治疗系膜增生性肾小球肾炎(MsPGN)的疗效。方法:治疗组56例,以肾络通治疗;对照组30例,以雷公藤多甙治疗。疗程为3个月。结果:治疗组完全缓解率和总有效率为25.0%和82.1%,显著高于对照组的20.0%和53.3%(P<0.05),而治疗组复发率仅8.7%,明显低于对照组的56.2%(P<0.01)。结论:说明肾络通是治疗MsPGN的有效方药之一。
|
关 键 词: | 肾络通 系膜增生性肾炎 临床观察 中医药疗法 |
修稿时间: | 2002年1月16日 |
Clinical Observation on Treatment of Mesangial Proliferative Glomerulonephritis by Shenluotong |
| |
Authors: | ZHAO Yu-yong CHEN Zhi-qiang YU Chun-quan |
| |
Institution: | ZHAO Yu-yong,CHEN Zhi-qiang,YU Chun-quan,et al College of Integrated Traditional and Western Medicine,Hebei Medical University,Shijiazhuang 050091 |
| |
Abstract: | To explore the clinical effect of Shenluotong (SLT) in treating mesangial proliferative glomeru-lonephritis (MsPGN). Methods: The patients with MsPGN allocated in the treated group ( n = 56) and the control group (n =30) were treated with SLT and Tripterygium glycosides respectively. The course was 3 months for both groups. Results: The complete remission rate and total effective rate in the treated group was 25.0% and 82.1% respectively, which was obviously higher than those in the control group, 20.0% and 53. 3 % , respectively ( P
|
| |
Keywords: | Shenluotong mesangial proliferative glomerulonephritis clinical observation |
本文献已被 CNKI 维普 万方数据 等数据库收录! |
| 点击此处可从《中国中西医结合杂志》浏览原始摘要信息 |
| 点击此处可从《中国中西医结合杂志》下载免费的PDF全文 |